Ying-Yi Qin
Overview
Explore the profile of Ying-Yi Qin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
481
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Xiang Y, Wang K, Qin Y, Liu Z, Yu H, Cheng Y, et al.
Eur J Surg Oncol
. 2024 Nov;
51(2):109492.
PMID: 39615296
Background: Preoperative hepatitis B virus (HBV) DNA level has been shown to correlate with the prognosis of patients with HBV-associated hepatocellular carcinoma (HCC) following liver resection, but its dynamic changes...
2.
Wang K, Xiang Y, Yu H, Cheng Y, Liu Z, Qin Y, et al.
Nat Med
. 2024 Jan;
30(3):708-715.
PMID: 38242982
Hepatocellular carcinoma (HCC), particularly when accompanied by microvascular invasion (MVI), has a markedly high risk of recurrence after liver resection. Adjuvant immunotherapy is considered a promising avenue. This multicenter, open-label,...
3.
Xiang Y, Wang K, Yu H, Li X, Cheng Y, Wang W, et al.
Hepatol Res
. 2022 May;
52(8):721-729.
PMID: 35536197
Aim: Transarterial chemoembolization (TACE) combined with a PD-1 inhibitor and TACE combined with a PD-1 inhibitor and lenvatinib have recently been reported as promising treatments to improve the prognosis of...
4.
Xiang Y, Sun J, Wu J, Wang K, Feng J, Wei Y, et al.
HPB (Oxford)
. 2022 May;
24(10):1703-1710.
PMID: 35523655
Background: Patients with hepatocellular carcinoma (HCC) bile duct tumor thrombus (BDTT) have a high rate of postoperative recurrence. We aimed to describe the patterns and kinetics of recurrence in BDTT...
5.
Wang K, Xiang Y, Yu H, Cheng Y, Qin Y, Wang W, et al.
Eur J Surg Oncol
. 2022 Jan;
48(6):1348-1355.
PMID: 34996665
Background: Microvascular invasion (MVI) is a significant risk factor affecting survival outcomes of patients after R0 liver resection (LR) for hepatocellular carcinoma (HCC). The current classification of MVI is not...
6.
Qin W, Yang Z, Li M, Chen Y, Zhao X, Qin Y, et al.
Gastroenterology
. 2020 Jan;
158(6):1713-1727.
PMID: 31972238
Background And Aims: The relationship between serum cholesterol level and development of hepatocellular carcinoma (HCC) remains unclear. We investigated the effects of serum cholesterol level on development of liver tumors...
7.
He Q, Wu C, Guo W, Wang Z, Zhao Y, Lu J, et al.
J Stroke Cerebrovasc Dis
. 2017 Sep;
26(11):2494-2500.
PMID: 28939046
Background: Stroke causes death and disability throughout the world and recurrent stroke events are more likely to be disabling or fatal. We conducted a hospital-based study to investigate the frequency...
8.
Zhang M, Qian W, Qin Y, He J, Zhou Y
World J Gastroenterol
. 2015 Apr;
21(14):4345-57.
PMID: 25892886
Aim: To summarize the evidence from randomized controlled trials (RCTs) regarding the effect of probiotics by using a meta-analytic approach. Methods: In July 2013, we searched PubMed, EMBASE, Ovid, the...
9.
Zhang C, Qin Y, Wei X, Yu F, Zhou Y, He J
Eur J Epidemiol
. 2014 Oct;
30(2):103-13.
PMID: 25354990
Studies that investigated the association between tea consumption and the risk of major cardiovascular events have reported inconsistent results. We conducted a meta-analysis of prospective observational studies in order to...
10.
Zhang C, Wang Z, Qin Y, Yu F, Zhou Y
PLoS One
. 2014 Sep;
9(9):e107060.
PMID: 25238614
Background: Observational studies suggest that B vitamin supplementation reduces cardiovascular risk in adults, but this association remains controversial. This study aimed to summarize the evidence from randomized controlled trials (RCTs)...